Startup | May 01, 2022
Genome Insight draws US $ 23 million in Series B Funding
Funds will be allocated to accelerate rapid production and high-end curation of whole genome sequences for its clinical application
Funds will be allocated to accelerate rapid production and high-end curation of whole genome sequences for its clinical application
The plant is expected to start commercial operations from Q4FY24
Cysoni is a bionic device that paces the heart with real-time respiratory modulation
Business EPS of €1.94, up 20.5% on a reported basis and 16.1% at CER, also benefitting from an improved effective tax rate
Revenue from operations up 15% to Rs. 758 crore in fourth quarter
Tembo and UFlex-Asepto have co-developed 100% renewable and recyclable paper straw solution that will be food grade, moisture-resistant and made from sustainably sourced papers
It is a multi-speciality healthcare brand which delivers a hassle-free experience for all types of cosmetic procedures and elective surgeries with personalized care
Erytech is evaluating valuable strategic options to leverage its Erycaps platform and its development and manufacturing capabilities with complementary assets and/or a broader corporate transaction
All the capex is being met through internal accruals only
The life sciences and pharmaceutical sectors suffer from hard-to-source biological materials, which translates into high costs in research and development
Subscribe To Our Newsletter & Stay Updated
